IFNA1 and chronic hepatitis C virus infection: A case report by LaRochelle and Karp43 documented a patient that developed RLS after IFN-α therapy for chronic hepatitis C. Between 50 and 75% of patients treated with recombinant IFN-α develop anti-interferon antibodies44.